Megan Mayer, Registered Nurse - Home Health Medicare: Not Enrolled in Medicare Practice Location: 2586 7th Ave E, Suite 302, North Saint Paul, MN 55109 Phone: 218-983-3900 |
Rosemarie Dammer, RN Registered Nurse - Home Health Medicare: Not Enrolled in Medicare Practice Location: 2586 7th Ave E Ste 302, North Saint Paul, MN 55109 Phone: 612-400-2066 Fax: 651-633-7301 |
Rochelle Marie Clarke, RN Registered Nurse - Home Health Medicare: Not Enrolled in Medicare Practice Location: 2586 7th Ave East Suite 302, North Saint Paul, MN 55109 Phone: 651-633-7300 |
Melissa Chadwick, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 2586 7th Ave E Ste 302, North Saint Paul, MN 55109 Phone: 651-633-7300 Fax: 651-633-7301 |
Amillia Adams, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 2562 7th Ave E Ste 201, North Saint Paul, MN 55109 Phone: 651-330-2550 |
Mrs. Amanda Lynn Aakre, Registered Nurse - Home Health Medicare: Not Enrolled in Medicare Practice Location: 2586 7th Ave E, Suite 302, North Saint Paul, MN 55109 Phone: 218-983-3900 Fax: 218-983-3902 |
Dawn Marie Sheldon, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 2562 7th Ave E Ste 201, North Saint Paul, MN 55109 Phone: 651-330-2550 |
News Archive
Results of two studies funded by Project A.L.S. and appearing in the advance online publication of Nature Neuroscience demonstrate that embryonic stem cells may provide a new tool for studying disease mechanisms and for identifying drugs to slow ALS, also known as Lou Gehrig's disease.
It's intuitive and scientifically shown that wearing a face covering can help reduce the spread of the novel coronavirus that causes COVID-19. But not all masks are created equal, according to new University of Arizona-led research.
The Society of Thoracic Surgeons today awarded G. Alexander Patterson, MD with the 2014 Earl Bakken Scientific Achievement Award during the Society's 50th Annual Meeting.
Henry Schein, Inc., the largest provider of health care products and services to office-based practitioners, today announced the launch of its Sleep Completeā¢ program, a new integrated comprehensive solution that provides all of the information and products necessary for the successful implementation of dental sleep medicine into the dental practice.
The U.S. Food and Drug Administration today approved Mvasi (bevacizumab-awwb) as a biosimilar to Avastin (bevacizumab) for the treatment of multiple types of cancer. Mvasi is the first biosimilar approved in the U.S. for the treatment of cancer.
› Verified 5 days ago